Team:UPO-Sevilla/Notebook/09 07
From 2010.igem.org
Line 19: | Line 19: | ||
<h2>Production Team</h2> | <h2>Production Team</h2> | ||
- | <p | + | <p> We performed the first overlapping PCR fo SDM. We performed three reactions to be able of obtain <i>fecI-fecR</i> and <i>fecR</i> parts by mutagenesis. In each reaction the mix is:</p> |
<p>37’5 ul H2O + 0,5ul UPO28* + 4 ul dNTP (10mM) + 5 ul Pfu buffer + 1 ul Pfu + 1 ul A-primer + 1 ul B-primer = 50 ul Vt</p> | <p>37’5 ul H2O + 0,5ul UPO28* + 4 ul dNTP (10mM) + 5 ul Pfu buffer + 1 ul Pfu + 1 ul A-primer + 1 ul B-primer = 50 ul Vt</p> |
Revision as of 23:50, 25 October 2010
September, 7th
Production Team
We performed the first overlapping PCR fo SDM. We performed three reactions to be able of obtain fecI-fecR and fecR parts by mutagenesis. In each reaction the mix is:
37’5 ul H2O + 0,5ul UPO28* + 4 ul dNTP (10mM) + 5 ul Pfu buffer + 1 ul Pfu + 1 ul A-primer + 1 ul B-primer = 50 ul Vt
Next we performed a preparative electrophoresis with PCR’s products. 0,8% gel electrophoresis showed that we obtained amplification enough to mutagenize fecR, but not fecI-fecR composite part. We isolated from gel the parts amplified, products of the first PCR reaction needed to the next one.
Assembly Team
We analyzed our work and determined the most important biobricks to be built. Most of them are still uncompleted, but time is running out. A new distribution of the sources was done this week. I began with the digestion of the unavailable biobricks and the purification of available ones. We lost 2+6 (not digested). After that, we proceeded to join the biobricks: (1+2)+(7+2), 4+3, 4+ pSB1C3 by ligation (o/n)
Assay Team
We started with a chemotaxis assays series today. We studied some possible strategies we could follow in order to see chemotaxis in bacteria (quantitative and qualitative assays).
We designed the method to put into practice the capillary assay developed by Adler and we prepared the material to carry it out.
Go to 3rd of September Go to 8th of September Return to Notebook